PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

NCT02819752 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped funding pulled

Conditions

Squamous Cell Carcinoma of the Head and Neck
Squamous Cell Carcinoma

Interventions

DRUG: Pembrolizumab
RADIATION: Radiotherapy
DRUG: Chemotherapy

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators

[object Object]
[object Object]